SCHEMBL5378435

SCHEMBL5378435

OCC1CCCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104405 0.89
Dioxane SCHEMBL5992701 0.82 ESR1 (0.34)
SCHEMBL18322679 0.81 ESR2 (0.37)
SCHEMBL18027850 0.80
SCHEMBL17617094 0.80
SCHEMBL1192557 0.80
Oxirane SCHEMBL96722 0.75 ESR1 (0.39)
SCHEMBL12993553 0.75
SCHEMBL6630034 0.75
SCHEMBL6627647 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110372703-A Five-ring heterocycles miazines compound and application thereof 罗欣生物科技(上海)有限公司 2019-10-25 CN disclosed
CN-107207851-A Method for producing photochromic cured product 株式会社德山 2017-09-26 CN disclosed
US-20070185086-A1 Pharmaceutical Compositions and Methods for Effecting Dopamine Release BENCHERIF MEROUANE 2007-08-09 US disclosed
US-7214686-B2 Pharmaceutical compositions and methods for effecting dopamine release TARGACEPT, INC. (US) 2007-05-08 US disclosed
WO-2004108668-A2 ALPHA-7 NEURONAL NICOTINIC RECEPTOR LIGANDS: COMPOSITIONS AND METHODS OF USE TARGACEPT, INC. (US) 2004-12-16 WO disclosed
US-20040220214-A1 Pharmaceutical compositions and methods for effecting dopamine release TARGACEPT, INC. 2004-11-04 US disclosed